Published in Immunology on December 01, 1990
Viruses and thyroiditis: an update. Virol J (2009) 1.43
Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci U S A (2003) 1.41
Association of the CTLA4 gene with Graves' disease in the Chinese Han population. PLoS One (2010) 1.09
FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice. Clin Exp Immunol (2001) 0.89
Enhanced expression of MHC class I molecules on cultured human thyroid follicular cells infected with reovirus through induction of type 1 interferons. Clin Exp Immunol (1995) 0.80
Reovirus delays diabetes onset but does not prevent insulitis in nonobese diabetic mice. J Virol (2006) 0.78
Association between the CTLA-4 +49A/G polymorphism and Graves' disease: A meta-analysis. Exp Ther Med (2012) 0.76
Autoreactive IgG elicited in mice by the non-dominant but pathogenic thyroglobulin peptide (2495-2511): implications for thyroid autoimmunity. Clin Exp Immunol (1994) 0.76
Molecular basis of reovirus virulence: role of the S1 gene. Proc Natl Acad Sci U S A (1977) 3.97
Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin. J Infect Dis (1980) 3.27
Subacute thyroiditis. Am J Med (1971) 2.16
Circulating viral and thyroid antibodies in subacute thyroiditis. J Clin Endocrinol Metab (1967) 2.01
Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity. J Exp Med (1981) 1.72
Binding of autologous erythrocytes to immature T-cells. Proc Natl Acad Sci U S A (1975) 1.43
Pathogenesis of viral infections. Basic concepts derived from the reovirus model. N Engl J Med (1985) 1.38
Suppression of the primary immune response in vivo to sheep red blood cells by B-cell mitogens. Immunology (1976) 1.31
Virus-induced thyroiditis. Endocrinology (1988) 0.93
In vitro responses of rat lymphocytes following adult thymectomy. III. Prevention by thymic factor of increased suppressor activity in the spleen. Cell Immunol (1976) 0.88
Intensive suppression of experimental allergic encephalomyelitis (EAE) by serum thymic factor and therapeutic implication for multiple sclerosis. Jpn J Exp Med (1982) 0.82
Prolongation of murine skin grafts by FTS and its synthetic analogues. Clin Exp Immunol (1981) 0.81
Promotion of sciatic nerve regeneration in rats by a new neurotrophic pyrimidine derivative MS-430. Gen Pharmacol (1995) 1.43
Basic behavior of migratory Schwann cells in peripheral nerve regeneration. Exp Neurol (1996) 1.19
Ullrich disease due to deficiency of collagen VI in the sarcolemma. Neurology (2004) 1.09
Increased midkine expression in hepatocellular carcinoma. Arch Pathol Lab Med (2000) 0.97
FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice. Clin Exp Immunol (2001) 0.89
Antigen expression associated with lymph node metastasis in gastric adenocarcinomas. Pathol Int (1994) 0.82
Monoclonal antibody to human midkine reveals increased midkine expression in human brain tumors. J Neuropathol Exp Neurol (1999) 0.81
Stimulation of lymphocytes of patients administered with a trypsin inhibitor, Trasylol (basic pancreatic trypsin inhibitor pharmaceutical), in vitro with BPTI and other several stimulants. Jpn J Exp Med (1975) 0.81
Thymic atrophy in type 2 reovirus infected mice: immunosuppression and effects of thymic hormone. Thymic atrophy caused by reo-2. Thymus (1991) 0.81
A newly synthesized neurotropic pyrimidine compound, MS-818, may activate migratory schwann cells in peripheral nerve regeneration. Brain Res (1998) 0.81
Midkine, a new neurotrophic factor, is present in glial cytoplasmic inclusions of multiple system atrophy brains. Acta Neuropathol (2000) 0.80
Effects of a nonapeptide thymic hormone on intestinal intraepithelial lymphocytes in mice following administration of 5-fluorouracil. Cell Immunol (1996) 0.79
Effect of administration of serum thymic factor (FTS) in calves and rabbits infected with bovine immunodeficiency-like virus. J Vet Med Sci (1995) 0.79
Vascular and stromal changes in irradiated and recovering rat thymus. Histol Histopathol (1999) 0.78
Rapid cataract formation in Marinesco-Sjögren syndrome. Pediatr Neurol (1994) 0.78
Effects of repeated administrations of facteur thymique sérique (FTS) on biochemical changes related to aging in senescence-accelerated mouse (SAM). Jpn J Pharmacol (1990) 0.78
tGS ganglioside induces peculiar morphological features in grafted dopaminergic cells and promotes motor recovery in rats with unilateral lesions in the nigrostriatal dopamine pathway. Brain Res (1990) 0.78
In vivo administration of serum thymic factor (FTS) prevents EMC-D virus-induced diabetes and myocarditis in BALB/cAJcl mice. Arch Virol (1996) 0.78
Subsequent epilepsy in very-low-birthweight infants: a long-term follow-up study from birth. Epilepsia (1995) 0.77
Resistance to pseudorabies virus with enhanced interferon production and natural killer cell activity in mice treated with serum thymic factor. Microbiol Immunol (1994) 0.77
Upregulation of nucleobindin expression in human-activated lymphocytes and non-Hodgkin's lymphoma. Pathol Int (1998) 0.76
Protective effects of serum thymic factor to Leptospira interrogans serovar Copenhageni infection in Mongolian gerbils. Vet Microbiol (1994) 0.76
Serum thymic factor as a radioprotective agent promoting survival after X-irradiation. Experientia (1990) 0.76
Strain differences in the immunogenicity of aggregated human IgG and the adjuvant action of lipopolysaccharide on the low-responder strain of mice. Jpn J Microbiol (1976) 0.76
Peripheral nerve regeneration in a silicone tube: effect of collagen sponge prosthesis, laminin, and pyrimidine compound administration. Neurol Med Chir (Tokyo) (1996) 0.76
Radioprotective effects of serum thymic factor in mice. Radiat Res (1992) 0.76
The effect of MS-818, a pyrimidine compound, on the regeneration of peripheral nerve fibers of mice after a crush injury. Acta Neuropathol (1995) 0.75
Augmentation with serum thymic factor of suppressive effects on retroviral tumor development in hosts immune to v-onc product. Leukemia (1997) 0.75
[Mouse fetal brain specific protein "GP68" is expressed in human tumor cells]. No To Shinkei (1991) 0.75
Bioavailability of a film-coated tablet of valproate in nonfasting volunteers. Jpn J Psychiatry Neurol (1987) 0.75
[Case of congenital muscular dystrophy in a 6-year-old girl --atypical Fukuyama type (subtype IV)]. No To Hattatsu (1984) 0.75
The effect of MS-818, newly synthesized pyrimidine compound, on fracture repair. Kobe J Med Sci (2000) 0.75
Congenital myopathy without specific features (minimal change myopathy). Neuropediatrics (1983) 0.75
Neurotropic pyrimidine heterocyclic compounds. II. Effects of novel neurotropic pyrimidine derivatives on astrocytic morphological differentiation. Biol Pharm Bull (1997) 0.75
Skin reaction and blast transformation of lymphocytes of guinea pigs sensitized with trypsin inhibitors. Jpn J Exp Med (1974) 0.75
Expressions of a 68kDa-glycoprotein (GP68) and laminin in the mesodermal tissue of the developing mouse embryo. Okajimas Folia Anat Jpn (1998) 0.75
Effects of neurotropic pyrimidine heterocyclic compound, MS-430, on cultured hepatic parenchymal and stellate cells. Life Sci (1997) 0.75
[Effect of 5'-AMP analogs on glycogen phosphorylase b]. Seikagaku (1968) 0.75
MS-430, a synthetic pyrimidine derivative, influences the intracellular signal transduction pathway leading to neuronal differentiation of PC12h cells. J Biochem (1998) 0.75
The neurotrophic pyrimidine heterocyclic compound MS-818 promotes the angiogenesis induced by basic FGF. Int J Clin Pharmacol Res (1995) 0.75
Activation of canine monocytes and polymorphonuclear cells by serum thymic factor (FTS) in vivo. J Vet Med Sci (1996) 0.75
A novel neurotrophic pyrimidine compound MS-818 enhances neurotrophic effects of basic fibroblast growth factor. J Neurosci Res (1998) 0.75
Serum valproate concentrations in epileptic children with favourable responses. Brain Dev (1987) 0.75
[The effect of MS-430, a synthetized pyrimidine compound, on regeneration of nerve fibers of rats after crush injury--a morphometric study]. J UOEH (1995) 0.75
Radioimmunoimaging of tumors with radioactive antibody against a glycoprotein (GP68) found in developing mouse brain. J Cancer Res Clin Oncol (1990) 0.75
The distribution and structure of FTS immunoreactive cells in the thymus of the mouse. Arch Histol Cytol (1988) 0.75
[Immunohistological demonstration of developmental protein GP68 in human tumor and embryonic tissues]. Gan No Rinsho (1990) 0.75
Induction of differentiation of human myeloid leukemia cells by novel synthetic neurotrophic pyrimidine derivatives. Exp Hematol (2001) 0.75
Benign childhood epilepsy with centro-temporal spikes: evolution of seizure types. Acta Paediatr Jpn (1988) 0.75
Increase of nerve regeneration capacity by new neurotrophic pyrimidine derivative MS-430. Gen Pharmacol (1998) 0.75
[Case of nemaline myopathy with severe respiratory and cardiac failure]. No To Hattatsu (1984) 0.75
[Case of Lennox-Gastaut syndrome improved remarkably by surgical treatment of a porencephalic cyst: a consideration on the generalized cortico-reticular epilepsy]. No To Hattatsu (1983) 0.75
A neurotrophic pyrimidine compound, MS-818, enhances EGF-induced restoration of gastric epithelial wounds in vitro. J Clin Gastroenterol (1998) 0.75
A thymic hormone protects mice from enteropathy during acute graft-versus-host disease. Microbiol Immunol (1997) 0.75
[Outcome in full-term asphyxiated neonates: correlation of perinatal factors and the prognosis]. No To Hattatsu (1987) 0.75
Suppression of retroviral tumors in hosts immune to viral oncogene product. Leukemia (1994) 0.75